Abstract
The anti-human tumour monoclonal antibody 791T/36 was conjugated to the cyclic dianhydride of DTPA and radio-labelled with 111In. The labelling method proved to be both simple and reliable and would be suitable for routine clinical use. Subsequent characterisation of this radio-pharmaceutical in vitro and in tumour-bearing hosts gave a strong indication as to its suitability for clinical tumour localisation studies.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armitage NC, Perkins AC, Pimm MV, Farrands PA, Baldwin RW, Hardcastle JD (1984) The localisation of an anti-tumour monoclonal antibody (791T/36) in gastrointestinal tumours. Br J Surg 71:407–412
Berche C, Mach J-P, Lumbroso JD, Langlais C, Aubry F, Buchegger F, Carrel S, Rougier P, Parmentier C, Tubiana M (1982) Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J 285:1447–1451
Eckelman WC, Karesh SH, Reba RC (1975) New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent. J Pharm Sci 64:704–706
Epenetos AA, Britton KE, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou J, Nimmon CC, Durbin H, Hawkins LE, Malpas JS, Bodmer WF (1982) Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast and gastrointestinal tumours. Lancet ii:999–1005
Fairweather DS, Bradwell AR, Dykes PW, Vaughan AT, Watson-James SF, Chandler S (1983) Improved tumour localisation using indium-111 labelled antibodies. Br Med J 287:167–170
Farrands PA, Perkins AC, Pimm MV, Hardy JG, Embleton MJ, Baldwin RW, Hardcastle JD (1982) Radioimmunodetection of human colorectal cancers by an anti-tumour monoclonal antibody. Lancet ii:397–400
Hnatowich DJ, Layne WW, Childs RL (1982) The preparation and labelling of DTPA coupled albumin. Int J Appl Radiat Isot 33:327–332
Krejcarek GE, Tucker KL (1977) Covalent attachment of chelating groups to macromolecules. Biochem Biophys Res Commun 77:581–585
Larson SM, Brown JP, Wright PW, Carrasquillo JA, Hellstrom I, Hellstrom KE (1983) Imaging of melanoma with I-131-labelled monoclonal antibodies. J Nucl Med 24:123–129
Mach J-P, Buchegger F, Forni M, Ritschard J, Berche C, Lumbroso J-D, Mchrege M, Giradet C, Accolla RS, Carrel S (1981) Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy. Immunology Today 2:239–249
Moshakis V, McIlhinney RAJ, Raghaven D, Neville AM (1981) Localization of human tumour xenografts after IV administration of radiolabelled monoclonal antibodies. Br J Cancer 44:91–99
Perkins AC, Armitage NC, Hardy JG, Wastie ML, Pimm MV, Hardcastle JD (1984) Imaging bone diseases using a radiolabelled anti-osteosarcoma monoclonal antibody. Nucl Med Commun 5:234–235
Perkins AC, Whalley DR, Hardy JG (1984) Physical approach for the reduction of dual radionuclide image subtraction artefacts in immunoscintigraphy. Nucl Med Commun 5:501–512
Pimm MV, Baldwin RW (1984) Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts. Eur J Cancer Clin Oncol 20:315–324
Pimm MV, Embleton MJ, Perkins AC, Price MR, Robins RA, Robinson GR, Baldwin RW (1982) In vivo localisation of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts. Int J Cancer 30:75–85
Pimm MV, Perkins AC, Baldwin RW (1984) Immunoscintigraphy of tumours: possibilities and limitations. behring Inst Mitt 74:61–71
Rainsbury RM, Ott RJ, Westwood JH, Kalirai TS, Coombes RC, McCrady VR, Neville AM, Gazel JC (1983) Localisation of metastatic breast carcinoma by a monoclonal antibody chelate labelled with indium-111. Lancet ii:934–938
Symonds EM, Perkins AC, Pimm MV, Baldwin RW, Hardy JG, Williams DA (in press) Clinical implications for immunoscintigraphy in patients with ovarian malignancy: a preliminary study using monoclonal antibody 791T/36. Br J Obstet Gynaecol
Williams MR, Perkins AC, Campbell FC, Pimm MV, Hardy JG, Wastie ML, Blamey RW, Bladwin RW (1984) The use of monoclonal antibody 791T/36 in the immunoscintigraphy of primary and metastatic carcinoma of the breast. Clin Oncol 10:375–381
Yeh SM, Sherman DG, Meares CF (1979) A new route to ‘bifunctional’ chelating agents: conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid. Anal Biochem 100:152–159
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Perkins, A.C., Pimm, M.V. & Birch, M.K. The preparation and characterisation of 111In-labelled 791T/36 monoclonal antibody for tumour immunoscintigraphy. Eur J Nucl Med 10, 296–301 (1985). https://doi.org/10.1007/BF00251299
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00251299